| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $2.7M | -71.4% |
| SG&A Expense | $5.8M | +5.5% |
| Net Income | -$8.3M | +43.2% |
| EPS (Basic) | -$0.32 | +96.5% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.9M | +219.8% |
| Current Assets | $5.5M | +69.1% |
| Total Assets | $6.2M | +55.9% |
| Current Liabilities | $2.3M | -26.7% |
| Total Liabilities | $2.4M | -24.7% |
| Stockholders' Equity | $3.8M | +414.0% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | +39.5% |
| Investing Cash Flow | -$20K | +91.4% |
| Financing Cash Flow | $10.6M | +470.7% |